Finance

Cisco Surges 17% Premarket; 20 Stocks Signal AI Capex Cycle

Cisco shares jumped roughly 17% in premarket trading after the company reported third-quarter revenue of $15.84 billion and adjusted EPS of $1.06, each topping consensus, and unveiled a restructuring to boost investments in AI, security and silicon. The stock move — and a broad list of premarket gainers and losers — has traders debating whether an AI-driven tech capital-expenditure cycle is underway.

Cisco Surges 17% Premarket; 20 Stocks Signal AI Capex Cycle

Key Takeaways

  • Cisco reported Q3 revenue of $15.84 billion versus estimates of $15.56 billion.
  • Adjusted EPS came in at $1.06, above consensus of $1.03.
  • Cisco said it would restructure to accelerate spending on AI, security and silicon, and raised FY26 revenue guidance.
  • Cisco shares rose about 17% premarket to roughly $119.8 following the results and plan.
  • Premarket movers included large gains in DXF (+107.8%), ALP (+40.8%) and AIIO (+36.4%), and notable losers such as MDXH (-41.5%) and DOCS (-21.3%).

People Involved

  • No specific individuals mentioned

Entities Involved

  • Cisco Systems (CSCO)Networking and infrastructure company; reported Q3 results and announced AI-focused restructuring
  • DXFPremarket gainer (reported up ~107.8%)
  • ALPPremarket gainer (reported up ~40.8%)
  • AIIOPremarket gainer (reported up ~36.4%)
  • LNKSPremarket gainer (reported up ~41.5%)
  • QUCYPremarket gainer (reported up ~36.5%)
  • AEHLPremarket gainer (reported up ~29.3%)
  • PGENPremarket gainer (reported up ~18.1%)
  • GOPremarket gainer (reported up ~17.7%)
  • Doximity (DOCS)Premarket loser (reported down ~21.3%)
  • MDxHealth (MDXH)Premarket loser (reported down ~41.5%)
  • WOKPremarket loser (reported down ~38.4%)
  • ALMUPremarket loser (reported down ~18.2%)
  • MSGMPremarket loser (reported down ~23.1%)

MarketMoodz Analysis

A beat on revenue and EPS plus an explicit pivot of spending toward AI, security and silicon gives Cisco a clear narrative: the company wants to be a plumbing play on any sustained AI-capex wave. For investors that means Cisco is signaling stronger demand for high-end networking, next-gen switches, security appliances and custom silicon — areas that require upfront capital spending by enterprises and cloud providers. The premarket 17% move prices in a lot of optimism; it also highlights how earnings and guidance can rapidly re-rate a large-cap hardware name when tied to AI demand.

The broader premarket list — with double- and triple-digit movers on both the upside and downside — maps to the same theme: speculative positioning around AI beneficiaries and laggards. Historically, capex cycles for infrastructure have lifted OEMs, component suppliers and software vendors in sequence; think switches and routers first, then optics and semiconductors, then software and security. If Cisco’s guidance and restructuring translate into higher bookings and order flow for suppliers, investors should see follow-through across networking peers, silicon designers and cybersecurity stocks.

Watch for three things next: Cisco’s detailed FY26 guidance and any line-item disclosure on restructuring charges and planned capex; order trends and bookings in the next two quarters; and commentary from other infrastructure vendors (Arista, Juniper) and large cloud customers about spending cadence. Premarket moves can reverse at the open; use position sizing and stop management if you’re trading the knee-jerk reaction rather than a confirmed multi-quarter demand shift.

See the mood, every market morning

Get the Dip Buyer's Checklist — the 10 checks before you buy any dip — plus the free Morning Mood email: the market's fear/greed gauge and one name off the Oversold Board, before the open.

Get the free checklist + daily email

Want the whole Board? See the Dip Buyer's Edge →

This article is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.